|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Ferri B, Campillo JA, Martinez-Sanchez MV, Minguela A. Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies. Biomedicines. 2025 Jan 10;13(1):156. doi: 10.3390/biomedicines13010156. PubMed PMID: 39857739; PubMed Central PMCID: PMC11760850.
AÑO: 2025; IF: 3.9
|
39857739
|
Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, Campillo JA, Lopez-Hernandez R, Gonzalez-Lopez R, Ruiz-Lorente I, Otalora-Alcaraz A, Ortuno-Hernandez C, Gimeno L, Ceballos-Francisco D, Muro M, Solana-Martinez E, Martinez-Camblor P, Minguela A. Diagnostic Utility of Bronchoalveolar Lavage Flow Cytometric Leukocyte Profiling in Interstitial Lung Disease and Infection. Biomolecules. 2025 Apr 17;15(4):597. doi: 10.3390/biom15040597. PubMed PMID: 40305365; PubMed Central PMCID: PMC12025232.
AÑO: 2025; IF: 4.8
|
|
Minguela A, Campillo JA, Aguilar Sanchis MI, Baeza Caracena A, Esquembre F, Novoa-Bolivar EM, Gonzalez-Lopez R, Otalora A, Ortuno-Hernandez C, Lopez-Hernandez R, Gimeno L, Ruiz-Lorente I, Ceballos D, Solana-Martinez E, Alcantara-Fructuoso J, Muro M, Ros JA. Ethylbenzene Exposure and Bronchoalveolar CD4/CD8 T Cells in Hypersensitivity Pneumonitis Development and Clinical Outcome. Biomedicines. 2025 Oct 24;13(11):2611. doi: 10.3390/biomedicines13112611. PubMed PMID: 41301706; PubMed Central PMCID: PMC12649851.
AÑO: 2025; IF: 3.9
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Cubillana PL, Aparicio TF, Egea LJA, Aviles JM, Iniguez GD, Martinez-Valls PLG, Server G, Ferri B, Campillo JA, Galindo F, Martinez-Sanchez MV, Minguela A. HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer. Oncoimmunology. 2025 Dec 31;14(1):2598920. doi: 10.1080/2162402X.2025.2598920. Epub 2025 Dec 12. PubMed PMID: 41384865; PubMed Central PMCID: PMC12710922.
AÑO: 2025; IF: 6.3
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Jesus Asensio Egea L, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Ferri B, Campillo JA, Galindo F, Boix F, Martinez-Sanchez MV, Martinez-Hernandez MD, Minguela A. Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancer. Front Cell Dev Biol. 2025 Sep 4;13:1632101. doi: 10.3389/fcell.2025.1632101. eCollection 2025. PubMed PMID: 40977889; PubMed Central PMCID: PMC12443833.
AÑO: 2025; IF: 4.3
|